Very Late Coronary Stent Thrombosis of a Newer-Generation Everolimus-Eluting Stent Compared With Early-Generation Drug-Eluting Stents

Randomized Comparison of Everolimus-Eluting Stent Versus Sirolimus-Eluting Stent Implantation for De Novo Coronary Artery Disease in Patients With Diabetes Mellitus (ESSENCE-DIABETES)

(2011) Won-Jang Kim et al.   CIRCULATION

Stent Thrombogenicity Early in High-Risk Interventional Settings Is Driven by Stent Design and Deployment and Protected by Polymer-Drug Coatings

(2011) Kumaran Kolandaivelu et al.   CIRCULATION

Everolimus-Eluting Versus Sirolimus-Eluting Stents

(2011) Antoinette de Waha et al.   Circulation-Cardiovascular Interventions

Randomized Comparison of Everolimus- and Paclitaxel-Eluting Stents

(2011) Gregg W. Stone et al.   JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY

Biodegradable Polymer Versus Permanent Polymer Drug-Eluting Stents and Everolimus- Versus Sirolimus-Eluting Stents in Patients With Coronary Artery Disease

(2011) Robert A. Byrne et al.   JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY

2-Year Follow-Up of a Randomized Controlled Trial of Everolimus- and Paclitaxel-Eluting Stents for Coronary Revascularization in Daily Practice

(2011) Pieter C. Smits et al.   JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY

Coronary Responses and Differential Mechanisms of Late Stent Thrombosis Attributed to First-Generation Sirolimus- and Paclitaxel-Eluting Stents

(2011) Gaku Nakazawa et al.   JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY

Randomized comparison of 6- versus 24-month clopidogrel therapy after balancing anti-intimal hyperplasia stent potency in all-comer patients undergoing percutaneous coronary intervention

(2010) Marco Valgimigli et al.   AMERICAN HEART JOURNAL

Comparisons of Baseline Demographics, Clinical Presentation, and Long-Term Outcome Among Patients With Early, Late, and Very Late Stent Thrombosis of Sirolimus-Eluting Stents

(2010) Takeshi Kimura et al.   CIRCULATION

Second-generation everolimus-eluting and paclitaxel-eluting stents in real-life practice (COMPARE): a randomised trial

(2010) Elvin Kedhi et al.   LANCET

Duration of Dual Antiplatelet Therapy after Implantation of Drug-Eluting Stents

(2010) Seung-Jung Park et al.   NEW ENGLAND JOURNAL OF MEDICINE

Everolimus-Eluting versus Paclitaxel-Eluting Stents in Coronary Artery Disease

(2010) Gregg W. Stone et al.   NEW ENGLAND JOURNAL OF MEDICINE

Drug-Eluting versus Bare-Metal Stents in Large Coronary Arteries

(2010) Christoph Kaiser et al.   NEW ENGLAND JOURNAL OF MEDICINE

Long-Term Clinical Outcome After a First Angiographically Confirmed Coronary Stent Thrombosis

(2009) Jochem W. van Werkum et al.   CIRCULATION

Correlation of Intravascular Ultrasound Findings With Histopathological Analysis of Thrombus Aspirates in Patients With Very Late Drug-Eluting Stent Thrombosis

(2009) Stéphane Cook et al.   CIRCULATION

Late stent malapposition risk is higher after drug-eluting stent compared with bare-metal stent implantation and associates with late stent thrombosis

(2009) A. K. M. Hassan et al.   EUROPEAN HEART JOURNAL

Delayed Arterial Healing and Increased Late Stent Thrombosis at Culprit Sites After Drug-Eluting Stent Placement for Acute Myocardial Infarction Patients

(2008) Gaku Nakazawa et al.   CIRCULATION

Differential Healing Responses in Polymer- and Nonpolymer-Based Sirolimus-Eluting Stents

(2008) Michael C. John et al.   JACC-Cardiovascular Interventions

Endothelial Cell Recovery Between Comparator Polymer-Based Drug-Eluting Stents

(2008) Michael Joner et al.   JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY